Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

491 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven L, French P, Hegi ME, Jakola AS, Platten M, Roth P, Rudà R, Short S, Smits M, Taphoorn MJB, von Deimling A, Westphal M, Soffietti R, Reifenberger G, Wick W. Weller M, et al. Among authors: preusser m. Nat Rev Clin Oncol. 2021 Mar;18(3):170-186. doi: 10.1038/s41571-020-00447-z. Epub 2020 Dec 8. Nat Rev Clin Oncol. 2021. PMID: 33293629 Free PMC article. Review.
Histopathologic assessment of hot-spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: a translational research project of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Preusser M, Heinzl H, Gelpi E, Schonegger K, Haberler C, Birner P, Marosi C, Hegi M, Gorlia T, Hainfellner JA; European Organization for Research and Treatment of Cancer Brain Tumor Group. Preusser M, et al. Cancer. 2006 Jul 1;107(1):162-70. doi: 10.1002/cncr.21973. Cancer. 2006. PMID: 16721804 Free article.
Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker.
Preusser M, Charles Janzer R, Felsberg J, Reifenberger G, Hamou MF, Diserens AC, Stupp R, Gorlia T, Marosi C, Heinzl H, Hainfellner JA, Hegi M. Preusser M, et al. Brain Pathol. 2008 Oct;18(4):520-32. doi: 10.1111/j.1750-3639.2008.00153.x. Epub 2008 Apr 8. Brain Pathol. 2008. PMID: 18400046 Free PMC article.
Current concepts and management of glioblastoma.
Preusser M, de Ribaupierre S, Wöhrer A, Erridge SC, Hegi M, Weller M, Stupp R. Preusser M, et al. Ann Neurol. 2011 Jul;70(1):9-21. doi: 10.1002/ana.22425. Ann Neurol. 2011. PMID: 21786296 Review.
Brain metastases: pathobiology and emerging targeted therapies.
Preusser M, Capper D, Ilhan-Mutlu A, Berghoff AS, Birner P, Bartsch R, Marosi C, Zielinski C, Mehta MP, Winkler F, Wick W, von Deimling A. Preusser M, et al. Acta Neuropathol. 2012 Feb;123(2):205-22. doi: 10.1007/s00401-011-0933-9. Epub 2012 Jan 3. Acta Neuropathol. 2012. PMID: 22212630 Review.
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours--a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Preusser M, Hoeftberger R, Woehrer A, Gelpi E, Kouwenhoven M, Kros JM, Sanson M, Idbaih A, Brandes AA, Heinzl H, Gorlia T, Hainfellner JA, van den Bent M. Preusser M, et al. Histopathology. 2012 May;60(6):885-94. doi: 10.1111/j.1365-2559.2011.04134.x. Epub 2012 Feb 15. Histopathology. 2012. PMID: 22335622 Clinical Trial.
Expression of BRAF V600E mutant protein in epithelial ovarian tumors.
Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P. Preusser M, et al. Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):159-64. doi: 10.1097/PAI.0b013e31825d7402. Appl Immunohistochem Mol Morphol. 2013. PMID: 22820660
491 results